Patents by Inventor Antoine Charles Olivier Henninot

Antoine Charles Olivier Henninot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QW DOSING OF GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF
    Publication number: 20230143604
    Abstract: The present disclosure provides GIP receptor agonist peptide compounds suitable for once per week dosing (QW), said peptide compounds having an activating action on GIP receptors and use of the GIP receptor agonist peptide as a medicament for the treatment and/or prevention of emesis, or a symptom or condition associated with emesis. Specifically, a GIP receptor agonist peptide containing a sequence represented by any of the formulas (I)-(V) or a salt thereof, and a medicament comprising the same are provided.
    Type: Application
    Filed: March 25, 2021
    Publication date: May 11, 2023
    Inventors: Antoine Charles Olivier HENNINOT, Derek Cecil COLE, Nicholas SCORAH
  • QD DOSING OF GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF
    Publication number: 20220227830
    Abstract: The present disclosure provides GIP receptor agonist peptide compounds suitable for once per day dosing (QD), said peptide compounds having an activating action on GIP receptors and use of the GIP receptor agonist peptide as a medicament for the treatment and/or prevention of emesis, or a symptom or condition associated with emesis. Specifically, a GIP receptor agonist peptide containing a sequence represented by any of the formulas (I)-(V) or a salt thereof, and a medicament comprising the same are provided.
    Type: Application
    Filed: December 17, 2021
    Publication date: July 21, 2022
    Inventors: Antoine Charles Olivier Henninot, Derek Cecil Cole, Nicholas Scorah